Citrus Bioflavonoid · Hesperidin Glucoside
Hesperidin is a flavanone glycoside abundantly found in citrus fruits, especially the white pith and inner peel of oranges, lemons, and tangerines. It's the most-consumed citrus flavonoid in the typical Western diet (50-200mg/day from juice and citrus consumption). Hesperidin has been used since the 1930s in European pharmaceuticals for chronic venous insufficiency and hemorrhoids (typically as Diosmin/Hesperidin combinations like Daflon), and modern research has expanded its applications to cardiovascular health, anti-inflammatory effects, and metabolic support.
Take with meals to improve absorption (Hesperidin is fat-soluble). For venous symptoms or hemorrhoidal flares, look for Diosmin/Hesperidin combination products (Daflon-style 500mg total). Acute hemorrhoidal protocol uses higher doses (3000mg/day Diosmin/Hesperidin) for first few days then standard 1000mg/day.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
Hesperidin's primary vascular mechanisms include strengthening capillary walls (reducing leakiness via stabilization of endothelial junctions), enhancing venous tone (mild norepinephrine-potentiating effect on venous smooth muscle), reducing inflammation in venous valves (anti-inflammatory effects on perivenous tissue), and supporting lymphatic drainage. The combined effects underlie the well-established efficacy in chronic venous insufficiency and hemorrhoidal flares.
Cardiovascular effects involve eNOS upregulation (improving endothelial NO production for vascular relaxation), modest reduction of vascular oxidative stress, and BP-lowering effect possibly via AT1 receptor antagonism and ACE inhibition (mild). Hesperidin also reduces platelet aggregation and may have modest antithrombotic effects, contributing to cardiovascular protection.
Anti-inflammatory mechanisms include NF-kB pathway inhibition (reducing TNF-alpha, IL-6, COX-2 expression), modulation of nitric oxide synthase activity, and direct antioxidant effects via the flavanone structure. Metabolic effects involve modest improvements in insulin sensitivity (mechanism via GLUT4 upregulation, AMPK activation), hepatic lipid metabolism (reduced hepatic triglyceride accumulation in animal models), and adipose tissue function. The Diosmin form is more bioavailable and is the form used in most pharmaceutical preparations.
Days 1-14: Acute vascular symptom relief.
Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.
Evidence boundary from the checked abstract: In addition, hesperidin could inhibit the IL6/STAT3 signaling pathway.
In addition, hesperidin could inhibit the IL6/STAT3 signaling pathway.
Evidence scope. This entry supports only the exact statement quoted from the live abstract; it does not independently verify OnePin's displayed dose, route, frequency, formulation, population, or broader mechanism.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Dose/route: 500mg; Oral; Daily. No checked live PubMed abstract verified this exact displayed dose, route, and frequency for the same molecule/formulation and relevant population.
Primary safety claim: Mild GI effects (nausea, abdominal pain) at higher doses. No checked live PubMed abstract directly verified this source-JSON safety claim at the displayed formulation, route, and regimen.
Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.
Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.
Hesperetin, the active metabolite
Oral (delayed by gut bacterial hydrolysis)
Low to moderate - hesperidin is rutinose-conjugated and requires gut bacterial hydrolysis to release active hesperetin aglycone. Diosmin form has better bioavailability.
Effects sustained with daily dosing. Acute vascular tone effects within hours; chronic vascular health effects build over weeks.
Hepatic conjugation (sulfation, glucuronidation), biliary and renal excretion of conjugates.
Storage. Store at room temperature (20-25C) in a cool, dry, dark place. Capsules and tablets shelf-stable for 24+ months. Powder may oxidize with prolonged air exposure - keep tightly sealed.
Classified as a dietary supplement in the US. Available widely over the counter. Diosmin/Hesperidin (Daflon) is approved as pharmaceutical in 100+ countries for chronic venous insufficiency and hemorrhoids. EU permits Hesperidin as a food supplement. Generally Recognized as Safe at typical supplement doses.
Put it to work
Open Hesperidin straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open Hesperidin in the app →Go deeper
The complete Hesperidin walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗Track it in OnePin. Log vials, draws, and protocols in the app.
Type a name, brand, or tool. Esc closes.